• American Dysfunction: Violence in American Society
  • the American society in a complex state of ..
  • In American Dysfunction, Chinese Find a Powerful …

I enclose a check made payable to The American Autonomic Society in the amount of $ ____

Journal of the American Society of Echocardiography

North American Menopause Society (NAMS) - Focused …

American Thyroid Association’s 2017 Stanbury Medal to Be Awarded to James A. Fagin, MD The…
Within the domain of early detection of prostate cancer, search strategies addressed the following subdomains: 1) efficacy of screening in reducing mortality from prostate cancer; 2) test characteristics of prostate cancer screening in asymptomatic men, including sensitivity, specificity, and predictive value; and 3) physical and psychological harms associated with screening. Abstracted information included the study setting and design, screening test, participant characteristics (including age, race/ethnicity, educational status, and socioeconomic status), study arms (eg, case and control definitions), proportion of participants screened, follow‐up duration, confirmatory tests, outcome measures (eg, mortality), and measure of associations (eg, hazard ratios). For the subdomain of screening harms, information on methods used for measuring harms (eg, anxiety questionnaire, general psychological distress/mental state questionnaire) was abstracted.

Multiple Organ Dysfunction Syndrome in Sepsis: …

American Thyroid Association’s 2017 Lewis E. Braverman Distinguished Award Lecture Delivered by Julie Ann Sosa,…
Infection is a devastating complication of any prosthetic surgery. Currently available inflatable prostheses have been modified in an attempt to reduce the risk of infection. One available device has an antibiotic coating consisting of rifampin and minocycline (American Medical Systems, Minnetonka, MN) and the other has a hydrophilic coating (Mentor Corporation, Santa Barbara, CA). A recently published industry-sponsored study45 demonstrates a statistically significant reduction of infection rate using the antibiotic-coated device from 1.61% to 0.68% at 180 days. A similar study has been published evaluating the efficacy of a hydrophilic-coated device that is immersed in an antibiotic pre-operatively. At 1-year follow-up, the infection rate for non-coated prosthesis was 2.07% compared to 1.06% for the same prosthesis with hydrophilic coating.46 Additional data are needed to confirm these initial findings.

 

American Physiological Society Journal | Home

Director, Cancer Screening, Cancer Control Science Department, American Cancer Society, Atlanta, GA
We acknowledge the members of the American Cancer Society (ACS) Prostate Cancer Advisory Committee (listed below) for their vital contributions to the development of this guideline. In addition, Robert J. Volk, PhD (The University of Texas M. D. Anderson Cancer Center, Houston, TX); Louise Walter, MD (University of California‐San Francisco, San Francisco, CA); and Chiranjeev Dash, MBBS, MPH and Idris Guessous, MD (Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta GA) made major contributions as external experts. We also thank the reviewers, including members of the ACS Primary Care Advisory Committee, the ACS Mission Outcomes Committee, and the ACS Board of Directors for their helpful comments and recommendations.

Director, Cancer and Aging Research, Behavioral Research Center, American Cancer Society, Atlanta, GA
The burden of suffering from prostate cancer in the United States is significant. In 2009, approximately 192,000 men were diagnosed with prostate cancer, and 27,000 men were expected to die from this disease. Approximately 2.2 million living American men have been diagnosed with prostate cancer, and some are living with metastatic disease, a painful and functionally limiting stage of the disease. Prostate cancer is by far the most commonly diagnosed cancer among American men and remains the second leading cause of cancer death in men. The PSA blood test has changed the landscape of prostate cancer, creating a dramatic rise in the incidence since its dissemination 20 years ago and helping to shift the stage of disease at the time of diagnosis to a much earlier and potentially more curable stage. However, testing for the early detection of prostate cancer remains a source of uncertainty and controversy.


Voices for PFD | | Voices for PFD

1. Montague, D.K., Barada, J.H., Belker, A.M., Levine, L.A., Nadig, P.W., Sharlip, I.D. et al: The American Urological Association Erectile Dysfunction Clinical Guidelines Panel Report on The Treatment of Organic Erectile Dysfunction. Baltimore, MD: American Urological Association, 1996

Anatomy and Sexual Dysfunction - Scientific American

The ACS recommends that asymptomatic men who have at least a 10‐year life expectancy should have an opportunity to make an informed decision with their health care provider about whether to be screened for prostate cancer, after receiving information about the uncertainties, risks, and potential benefits associated with prostate cancer screening. Prostate cancer screening should not occur without an informed decision‐making process. Men at average risk should receive this information beginning at age 50 years. Men at higher risk, including African American men and men who have a first‐degree relative (father or brother) diagnosed with prostate cancer before age 65 years, should receive this information beginning at age 45 years. Men at appreciably higher risk (multiple family members diagnosed with prostate cancer before age 65 years) should receive this information beginning at age 40 years. Men should either receive this information directly from their health care providers or be referred to reliable and culturally appropriate sources. Patient decision aids are helpful in preparing men to make a decision whether to be tested. For men who are unable to decide, the screening decision can be left to the discretion of the health care provider, who should factor into the decision his or her knowledge of the patient's general health preferences and values.

The Dysfunction Of Modern Society Is Proof That …

The literature review began with an environmental scan of existing guidelines and guidance developed by other organizations (eg, the NCCN, ASCO, and the Children's Oncology Group []), specific medical centers (eg, The University of Texas MD Anderson Clinical Tools and Resources Breast Cancer Survivorship algorithm, the US Preventive Services Task Force, and the American Association of Clinical Endocrinologists), individual publications available from other countries (eg, the Australian Cancer Survivorship Center), and publications from other expert panels (eg, the Breast Health Global Initiative guidelines).